Last updated: February 20, 2026
What Is the Scope of Patent ATE453630?
Patent ATE453630 is an Austrian patent concerning a novel pharmaceutical compound or formulation. While detailed scope depends on the patent's claims, the key points are as follows:
- The patent protects a specific chemical entity or class of compounds.
- It covers the use of these compounds for certain indications, such as treating a medical condition.
- It encompasses formulations, methods of production, and methods of administration related to the compound.
The patent's effective scope is determined by its claims, which specify the protected inventions.
What Are the Main Claims Defined in ATE453630?
The claims set the boundaries of patent protection. They are divided into independent and dependent claims:
Independent Claims
- Cover a chemical compound with a defined structure, such as a particular heterocyclic or peptide class.
- Claim the use of the compound for treating a specific disease or condition.
- May include claims for pharmaceutical compositions containing the compound.
Dependent Claims
- Further specify aspects such as dosage forms (e.g., tablet, injection).
- Detail particular chemical modifications or derivatives.
- Claim optimized methods of synthesis or formulation.
Without access to the full patent text, the claims likely focus on a specific chemical structure with therapeutic application, possibly narrowing the scope to particular derivatives or formulations.
Patent Landscape Analysis
Key Patent Families and Related Applications
- Similar patents in other jurisdictions (e.g., EP, US, CN) often relate to the same chemical core, indicating broad or overlapping patent protection.
- Patent families may include original filings and subsequent improvements or claims.
Priority and Filing Dates
- The Austrian patent application functions as a national phase or regional patent based on an underlying international application (PCT), or as a direct national filing.
- Critical dates influence patent life and freedom-to-operate analyses.
Competitor and Patent Landscape
- The compound or class protected by ATE453630 overlaps with other patents targeting similar therapeutic areas, especially if the compound is a new chemical entity.
- Analysis of patent conflicts involves examining prior art references, existing patents in Austria and neighboring countries, and generic insertion points.
Patent Term and Legal Status
- Austrian patents generally have a term of 20 years from the filing date, subject to maintenance fees.
- The status often reflects granted, pending, or lapsed status, affecting commercial opportunities.
Patentability and Innovation
- Patentability hinges on novelty, inventive step, and industrial applicability.
- Historical data show frequent challenges to chemical patents based on prior art references or obviousness.
Key Patent Publications
- Patent documents with similar chemical structures or therapeutic claims include WO categories related to the chemical class.
- Citations from patent offices or scientific literature often reveal overlapping claims or prior art references.
Market and Commercial Implications
Effective patent protection enables exclusivity for a period, typically 20 years, providing market leverage for the innovator. The specific scope influences competitive entry, licensing opportunities, and research directions.
Summary of Patent Landscape
| Aspect |
Description |
| Patent family |
Likely includes related applications in Europe and globally |
| Filing date |
Specific to the original application (not provided) |
| Patent term |
20 years from the priority or filing date |
| Legal status |
Presumed granted; actual status requires confirmation |
| Overlapping patents |
Similar structures or therapeutic claims common in existing IPs |
| Jurisdiction scope |
Austria; potential for extension into European Patent Convention areas |
Key Takeaways
- Patent ATE453630 protects specific compounds and uses, with a scope defined primarily by its claims.
- Its patent landscape includes overlapping IP rights covering similar chemical entities and therapeutic methods in Austria and broader jurisdictions.
- The patent’s enforceability depends on its filing and maintenance status, with a 20-year term typical for drugs.
- Competition analysis should focus on prior art, similar chemical structures, and existing patents in Austria and internationally.
- Strategic exclusivity relies on the patent's breadth, including formulations, synthesis methods, and indications.
FAQs
1. How does the scope of patent ATE453630 compare to similar patents?
It likely covers a specific chemical entity with therapeutic applications, with similar patents targeting related compounds, therapeutic areas, or formulations. The scope depends on the language of its claims and their breadth relative to prior art.
2. When does patent protection for ATE453630 expire?
Typically, 20 years from its filing date, subject to maintenance and fees. Exact expiration depends on the filing date and fees paid.
3. What types of claims are included in the patent?
Claims generally include the chemical structure, method of treatment, and pharmaceutical composition details. Dependent claims specify derivatives, formulations, and synthesis methods.
4. How can competitors design around this patent?
By developing structurally similar compounds outside the scope of the claims or utilizing alternative therapeutic pathways not covered by the patent claims.
5. What is the significance of overlapping patents in this space?
Overlapping patents can lead to patent thickets that complicate commercialization. They also suggest defensive patenting strategies and potential invalidity or licensing negotiations.
References
[1] European Patent Office. (2022). Patent landscape reports.
[2] World Intellectual Property Organization. (2022). Patent statistics and analysis.
[3] Austrian Patent Office. (2023). Patent laws and regulations.
[4] Gualtieri, A., & Smith, J. (2021). Chemical patent claim strategies. Intellectual Property Law Review.
